RTLS Technology Innovator Continues To Build Highly Experienced Governance and Leadership Team
Stamford (January 13, 2015) Sonitor Technologies, the global RTLS technology innovator, today announced that it has appointed Carl Christian Gilhuus-‐Moe and Hans Thomas Holbye to its board of directors. Gilhuus-‐Moe and Holbye bring substantial global medical technology, business and finance experience to the Sonitor board.
A seasoned medical technologist and executive, Carl Christian Gilhuus-‐Moe, PhD, trained at the Swedish Institute of Management, the Sloan School of Management at the Massachusetts Institute of Technology and earned his PhD in biochemistry from the University of Oslo. He is the Chairman of the Board of Oslo Medtech, a group of hospital, finance, knowledge and research institutions focusing on medical technology innovation and facilitates development of medtech products and services. Gilhuus-‐Moe is also a Senior Advisor of NeoMed Management, a Europe-‐ based venture capital fund focused on international healthcare and medical technology. In addition, he sits on the board of directors of JenaValve Technology, GmbH, and has served as a board member of Alertis Medical AS, Clavis Pharma ASA, Harbinger Medical, Inc. and NeoRad AS.
Previously Gilhuus-‐Moe served as Chairman of the Board for both SINTEF-‐Unimed (Norweigian Institute of Technology) and The European Committee for Clinical Laboratory Standardization (ECCLS), as well as a member of the executive group, Vice President and Head of Hafslund Nycomed ASA's diagnostic division.
Hans Thomas Holbye earned an Msc Business and Administration degree from BI Norwegian Business School. He is the Managing Director and CEO of Johs. Hansen Rederi AS and previously served as Finance Manager at IBM Norway and CFO and Head of the Investment Division of The Torvald Klaveness Group. Holbye sits on several Norwegian company boards.
Per Heidenreich, Sonitor Technologies Executive Chairman of The Board, commented, “We could not be more pleased to add such eminent individuals to our board. Carl Christian and Hans Thomas clearly have a unique blend of technical and global business experience and capabilities that will help steer our growing company into the future with our strong team of board members and advisors. The timing could not be better as the markets for RTLS in healthcare, hospitality and beyond are gaining momentum.”
Additional members of Sonitor Technologies’ Board of Directors include company founder Ole B. Hovind, M.D. and Per Grobstok , Chairman of Service Invest AS. The
U.S. Advisory Board members include Robert A. Chernow, Founder and President of Educational Services for Entrepreneurship and former President and Chief Executive Officer, New York and Presbyterian Health Plan; James M. Cotter, J.D., Co-‐ founder of Breedon Capital Management and former Vice Chairman and Partner at Simpson Thacher & Bartlett; David S. Taylor, CIO of Stamford Hospital, and Joe Toce, Managing Director of WTAS. (http://sonitor.com/about-‐sno-‐board)
About Sonitor Technologies
Sonitor Technologies’ tiered resolution Real Time Locations Systems (RTLS), with patented High Definition Ultrasound capabilities, are specifically developed and designed for indoor positioning in complex environments. Sonitor has developed the healthcare industry’s most advanced open integration RTLS platform, Sonitor Sense™, a wireless system which supports a wide range of applications to make hospital operations more efficient. Sonitor is selected by world-‐class partners to build industry-‐ leading solutions for global deployment.